EQT Life Sciences — 2024 Investments
9 investments dated 2024 · listed companies and verified rows first · show all
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersSambrinvestWallonie EntreprendreEQT
Tubulis develops antibody-drug conjugates (ADCs) for cancer treatment, using proprietary conjugation platform technologies to create tumor-targeting therapeutics.
BiotechDeep TechMedical DevicesPlanegg-Martinsried, DE
Dominik Schumacher(Co-founder & CEO)inJonas Helma-Smets(Co-founder & Chief Scientific Officer)Christian Hackenberger(Scientific Co-founder)
Co-investorsAndera PartnersBioMedPartnersNexTech VenturesAscenta CapitalBayern KapitalFrazier Life Sciences+7 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresSeroba Life SciencesEurazeoIdinvest Partners+1 more
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(President & Chief Executive Officer)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Board seatFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth Ventures+4 more
Biotech
Co-investorsKurma PartnersSofinnova PartnersJohnson & Johnson Innovation – JJDCM VenturesSR One Capital Management
NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.
FemTechHealthtechMedical DevicesGalway, IE
Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)
Co-investorsCatalytic Impact FoundationTMC Venture FundEnterprise Ireland
Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsAphelion CapitalInnvotec Ltd.Northern GritstoneSectoral Asset Management
VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.
AI & Machine LearningData & InfrastructureFintech
Co-investorsAIN VenturesMultiball CapitalDroia VenturesEurazeoKurma PartnersPureos Bioventures
VICO is an online platform for finding verified furnished monthly housing — rooms, studios, and apartments — aimed at students, young professionals, and digital nomads relocating to a new city.
B2B MarketplacesConsumerMarketplacesPropTechTravel & HospitalityMedellín, CO
Manuel FranzinTilman Burfeindin
Co-investors500 GlobalDroia VenturesEurazeoKurma PartnersPureos Bioventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















.jpeg)











